Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced …

Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced ...